Immunotherapy for malignant glioma: current approaches and future directions

  • Sikorski C
  • Lesniak M
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Traditional therapies for the treatment of malignant glioma have failed to make appreciable gains regarding patient outcome in the last decade. Therefore, immunotherapeutic approaches have become increasingly popular in the treatment of this cancer. This article reviews general immunology of the central nervous system and the immunobiology of malignant glioma to provide a foundation for understanding the rationale behind current glioma immunotherapies. A review of currently implemented immunological treatments is then provided with special attention paid to the use of vaccines, gene therapy, cytokines, dendritic cells and viruses. Insights into future and developing avenues of glioma immunotherapy, such as novel delivery systems, are also discussed

Author-supplied keywords

  • CENTRAL-NERVOUS-SYSTEM
  • GENE
  • GLIOMA
  • Gene Therapy
  • Nervous System
  • SYSTEM
  • Viruses
  • cancer
  • central nervous system
  • cytokine
  • cytokines
  • dendritic
  • dendritic cell
  • dendritic cells
  • immunology
  • immunotherapy
  • review
  • therapy
  • vaccine
  • vaccines

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

There are no full text links

Authors

  • C W Sikorski

  • M S Lesniak

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free